InnoCare Pharma and Eli Lilly enter a landmark collaboration agreement valued at up to $3.35 billion to develop new cancer and autoimmune disease treatments, including $100 million upfront and $3.25 ...

Rasayan Labs introduces a revolutionary AI-native platform for drug discovery at ICT Mumbai, streamlining the process of compound synthesis and ADMET prediction while providing free access to academic ...

Mumbai: Glenmark Pharmaceuticals has announced to have secured Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its formulations manufacturing facility in Goa.

Zydus Lifesciences is shifting its focus towards specialty medicines and innovative products to foster growth and address ...

Anthropic reveals its Claude AI has identified a unique enzyme system similar to CRISPR, marking a significant breakthrough in their biology research and drug-related efforts.

In response to the Karnataka FDA's recent crackdown on counterfeit drugs, Pfizer India emphasizes its commitment to patient ...

Syneos Health has inaugurated a new Global Life Sciences and Technology Centre in Hyderabad, India, marking its largest site in Asia. This center aims to enhance drug development with a focus on AI ...

Eris Lifesciences has announced the appointment of Akhil Awasthi as a Non-Executive Director, bringing over 30 years of investment experience to the board. His expertise in private equity and ...

Roche's experimental drug, enicepatide, delivers significant weight loss and improved blood sugar control in type-2 diabetes patients according to Phase 2 trial results. With a 15.5% weight loss and ...

Novo Nordisk's CEO envisions a future where weight-loss pills capture 50% of the global obesity drug market by 2030, shifting ...

Novo Nordisk, the maker of Ozempic, aims to enter the hair-loss market as part of its strategy to diversify and leverage its ...

Cohance Lifesciences' API manufacturing site in Andhra Pradesh has received a Form 483 with five observations from the FDA, ...